. . . . . . . "[The primary end-points were HBV e antigen (HBeAg) seroconversion with HBV-DNA?<?2000?IU/mL 24 weeks post-therapy (HBeAg-positive patients) and HBV-DNA?<?2000?IU/mL 24 weeks after peg-IFN (HBeAg-negative patients).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:35+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .